Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics

Disease Markers

Volumn 2016, Issue , 2016, Pages

  Shi, Ting ^a   Gao, Ge ^a   Cao, Yingli ^a  

^a Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER;

BIOLOGICAL FUNCTIONS; BODY FLUID; CANCER CELL LINE; CANCER DIAGNOSIS; CANCER TISSUE; DIAGNOSTIC VALUE; FUTUROLOGY; PROTEIN EXPRESSION; PROTEIN SECRETION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; RNA EXTRACTION; BLOOD; CHEMISTRY; EARLY CANCER DIAGNOSIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOLECULAR DIAGNOSIS; NEOPLASMS; PRACTICE GUIDELINE; SALIVA; STANDARDS; STOMACH JUICE; URINE;

BIOMARKERS, TUMOR; EARLY DETECTION OF CANCER; GASTRIC JUICE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RNA, LONG NONCODING; SALIVA;

EID: 84969174845     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2016/9085195     Document Type: Review

References (63)

1. C. P. Ponting and T. G. Belgard, "Transcribed dark matter: meaning or myth?" Human Molecular Genetics, vol. 19, no. 2, pp. R162-R168, 2010.
2. O. Wapinski and H. Y. Chang, "Long noncoding RNAs and human disease, " Trends in Cell Biology, vol. 21, no. 6, pp. 354-361, 2011.
3. C. A. Brosnan and O. Voinnet, "The long and the short of noncoding RNAs, " Current Opinion in Cell Biology, vol. 21, no. 3, pp. 416-425, 2009.
4. M. V. Iorio and C. M. Croce, "MicroRNAdysregulation in cancer: diagnostics, monitoring and therapeutics. Acomprehensive review, " EMBO Molecular Medicine, vol. 4, no. 3, pp. 143-159, 2012.
5. J. A. Weber, D. H. Baxter, S. Zhang et al., "The microRNA spectrum in 12 body fluids, " Clinical Chemistry, vol. 56, no. 11, pp. 1733-1741, 2010.
6. S. Molina-Pinelo, R. Suárez, M. D. Pastor et al., "Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies, " DiseaseMarkers, vol. 32, no. 4, pp. 221-230, 2012.
7. N. Kosaka, H. Izumi, K. Sekine, and T. Ochiya, "MicroRNA as a new immune-regulatory agent in breast milk, " Silence, vol. 1, no. 1, article 7, 2010.
8. H. Qu, W. Xu, Y. Huang, and S. Yang, "Circulating miRNAs: promising biomarkers of human cancer, " Asian Pacific Journal of Cancer Prevention, vol. 12, no. 5, pp. 1117-1125, 2011.
9. R. Duttagupta, R. Jiang, J. Gollub, R. C. Getts, and K.W. Jones, "Impact of cellular miRNAs on circulating miRNA biomarker signatures, " PLoS ONE, vol. 6, no. 6, Article ID e20769, 2011.
10. H. I. Pass, D.G. Beer, S. Joseph, and P. Massion, "Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer, "Thoracic Surgery Clinics, vol. 23, no. 2, pp. 211-224, 2013.
11. T. R. Mercer, M. E. Dinger, and J. S. Mattick, "Long non-coding RNAs: insights into functions, " Nature Reviews Genetics, vol. 10, no. 3, pp. 155-159, 2009.
12. Y. Huang, N. Liu, J. P. Wang et al., "Regulatory long non-coding RNA and its functions, " Journal of Physiology and Biochemistry, vol. 68, no. 4, pp. 611-618, 2012.
13. H. Zhang, Z. Chen, X. Wang, Z. Huang, Z. He, and Y. Chen, "Long non-coding RNA: a new player in cancer, " Journal of Hematology and Oncology, vol. 6, no. 1, article 37, 2013.
14. M.-T. Qiu, J.-W. Hu, R. Yin, and L. Xu, "Long noncoding RNA: an emerging paradigm of cancer research, " Tumor Biology, vol. 34, no. 2, pp. 613-620, 2013.
15. J. E. Wilusz, H. Sunwoo, and D. L. Spector, "Long noncoding RNAs: functional surprises from the RNA world, " Genes and Development, vol. 23, no. 13, pp. 1494-1504, 2009.
16. S. Xu, S. Sui, J. Zhang et al., "Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4881-4891, 2015.
17. Q. Ji, X. Liu, X. Fu et al., "Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway, " PLoS ONE, vol. 8, no. 11, Article ID e78700, 2013.
18. T. Arita, D. Ichikawa, H. Konishi et al., "Circulating long non-coding RNAs in plasma of patients with gastric cancer, " Anticancer Research, vol. 33, no. 8, pp. 3185-3194, 2013.
19. S. Ren, F. Wang, J. Shen et al., "Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer, " European Journal of Cancer, vol. 49, no. 13, pp. 2949-2959, 2013.
20. D. G. Weber, G. Johnen, S. Casjens et al., "Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, "BMC Research Notes, vol. 6, article 518, 2013.
21. P. Gresner, J. Gromadzinska, and W. Wasowicz, "Reference genes for gene expression studies on non-small cell lung cancer, " Acta Biochimica Polonica, vol. 56, no. 2, pp. 307-316, 2009.
22. X. Zhou, C. Yin, Y. Dang, F. Ye, and G. Zhang, "Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer, " Scientific Reports, vol. 5, Article ID 11516, 2015.
23. K. Trajkovic, C. Hsu, S. Chiantia et al., "Ceramide triggers budding of exosome vesicles into multivesicular endosomes, " Science, vol. 319, no. 5867, pp. 1244-1247, 2008.
24. R. M. Johnstone, "Exosomes biological significance: a concise review, " Blood Cells, Molecules, and Diseases, vol. 36, no. 2, pp. 315-321, 2006.
25. X. Huang, T. Yuan, M. Tschannen et al., "Characterization of human plasma-derived exosomal RNAs by deep sequencing, " BMC Genomics, vol. 14, article 319, 2013.
26. Q. Li, Y. Shao, X. Zhang et al., "Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer, " Tumor Biology, vol. 36, no. 3, pp. 2007-2012, 2015.
27. J. D. Arroyo, J. R. Chevillet, E. M. Kroh et al., "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
28. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, "Export of microRNAs and microRNA-protective protein by mammalian cells, " Nucleic Acids Research, vol. 38, no. 20, pp. 7248-7259, 2010.
29. P. Ji, S. Diederichs, W. Wang et al., "MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer, " Oncogene, vol. 22, no. 39, pp. 8031-8041, 2003.
30. L. H. Schmidt, T. Spieker, S. Koschmieder et al., "The long noncoding MALAT-1 RNA indicates a poor prognosis in nonsmall cell lung cancer and induces migration and tumor growth, " Journal of Thoracic Oncology, vol. 6, no. 12, pp. 1984-1992, 2011.
31. K. Tano, R. Mizuno, T. Okada et al., "MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes, " FEBS Letters, vol. 584, no. 22, pp. 4575-4580, 2010.
32. L. Shen, L. Chen, Y. Wang, X. Jiang, H. Xia, and Z. Zhuang, "Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer, " Journal of Neuro-Oncology, vol. 121, no. 1, pp. 101-108, 2015.
33. T. Gutschner, M. Hämmerle, M. Eimann et al., "The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells, " Cancer Research, vol. 73, no. 3, pp. 1180-1189, 2013.
34. F. Guo, F. Yu, J. Wang et al., "Expression of MALAT1 in the peripheralwhole blood of patients with lung cancer, " Biomedical Reports, vol. 3, no. 3, pp. 309-312, 2015.
35. S. Ren, Z. Peng, J.-H. Mao et al., "RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings, " Cell Research, vol. 22, no. 5, pp. 806-821, 2012.
36. S. Ren, Y. Liu, W. Xu et al., "Long noncoding RNAMALAT-1 is a new potential therapeutic target for castration resistant prostate cancer, "The Journal of Urology, vol. 190, no. 6, pp. 2278-2287, 2013.
37. B. Djavan, A. Zlotta, M. Remzi et al., "Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1, 051 men, " Journal of Urology, vol. 163, no. 4, pp. 1144-1149, 2000.
38. F. Wang, S. Ren, R. Chen et al., "Development and prospective multicenter evaluation of the long noncodingRNAMALAT-1 as a diagnostic urinary biomarker for prostate cancer, " Oncotarget, vol. 5, no. 22, pp. 11091-11102, 2014.
39. H. Song, W. Sun, G. Ye et al., "Long non-coding RNAexpression profile in human gastric cancer and its clinical significances, " Journal of Translational Medicine, vol. 11, article 225, 2013.
40. I. J. Matouk, S. Mezan, A. Mizrahi et al., "The oncofetal H19 RNA connection: hypoxia, p53 and cancer, " Biochimica et Biophysica Acta, vol. 1803, no. 4, pp. 443-451, 2010.
41. Y. Hao, T. Crenshaw, T. Moulton, E. Newcomb, and B. Tycko, "Tumour-suppressor activity of H19 RNA, " Nature, vol. 365, no. 6448, pp. 764-767, 1993.
42. H. Li, B. Yu, J. Li et al., "Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer, " Oncotarget, vol. 5, no. 8, pp. 2318-2329, 2014.
43. E. L. Kim, R. Wüstenberg, A. Rübsam et al., "Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells, " Neuro-Oncology, vol. 12, no. 4, pp. 389-400, 2010.
44. F. Yang, J. Bi, X. Xue et al., "Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells, " FEBS Journal, vol. 279, no. 17, pp. 3159-3165, 2012.
45. M. Zhuang, W. Gao, J. Xu, P. Wang, and Y. Shu, "The long noncoding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1, " Biochemical and Biophysical Research Communications, vol. 448, no. 3, pp. 315-322, 2014.
46. R. Kogo, T. Shimamura, K. Mimori et al., "Long noncoding RNAHOTAIR regulates polycomb-dependent chromatinmodification and is associated with poor prognosis in colorectal cancers, " Cancer Research, vol. 71, no. 20, pp. 6320-6326, 2011.
47. Z.-H. Wu, X.-L. Wang, H.-M. Tang et al., "Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer, " Oncology Reports, vol. 32, no. 1, pp. 395-402, 2014.
48. B. Cai, Z. Wu, K. Liao, and S. Zhang, "Long noncoding RNA HOTAIR can serve as a common molecularmarker for lymph node metastasis: a meta-analysis, " Tumor Biology, vol. 35, no. 9, pp. 8445-8450, 2014.
49. J. L. Rinn, M. Kertesz, J. K. Wang et al., "Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs, " Cell, vol. 129, no. 7, pp. 1311-1323, 2007.
50. M.-C. Tsai, O. Manor, Y. Wan et al., "Long noncoding RNA as modular scaffold of histone modification complexes, " Science, vol. 329, no. 5992, pp. 689-693, 2010.
51. R. A. Gupta, N. Shah, K. C. Wang et al., "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis, " Nature, vol. 464, no. 7291, pp. 1071-1076, 2010.
52. H. Wu, H. Zeng, A. Dong et al., "Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations, " PLoS ONE, vol. 8, no. 12, Article IDe83737, 2013.
53. M. Svoboda, J. Slyskova, M. Schneiderova et al., "HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients, " Carcinogenesis, vol. 35, no. 7, pp. 1510-1515, 2014.
54. E. A. Gibb, K. S. S. Enfield, G. L. Stewart et al., "Long noncoding RNAs are expressed in oral mucosa and altered in oral premalignant lesions, " Oral Oncology, vol. 47, no. 11, pp. 1055-1061, 2011.
55. J. Wu and H. Xie, "Expression of long noncoding RNA-HOX transcript antisense intergenic RNA in oral squamous cell carcinoma and effect on cell growth, " Tumor Biology, vol. 36, no. 11, pp. 8573-8578, 2015.
56. Y. Wu, L. Zhang, L. Zhang et al., "Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma, " International Journal of Oncology, vol. 46, no. 6, pp. 2586-2594, 2015.
57. C. Wang, X. Liu, Z. Chen et al., "PolycombgroupproteinEZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma, " Molecular Carcinogenesis, vol. 52, no. 3, pp. 229-236, 2013.
58. L. Liu, Z. Xu, L. Zhong et al., "Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma, " BJU International, vol. 117, no. 2, pp. 351-362, 2016.
59. H. Tang, Z. Wu, J. Zhang, and B. Su, "Salivary lncRNA as a potential marker for Oral squamous cell carcinoma diagnosis, " Molecular Medicine Reports, vol. 7, no. 3, pp. 761-766, 2013.
60. Q. Pang, J. Ge, Y. Shao et al., "Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance, " Tumor Biology, vol. 35, no. 6, pp. 5441-5447, 2014.
61. W.-J. Cao, H.-L. Wu, B.-S. He, Y.-S. Zhang, and Z.-Y. Zhang, "Analysis of long non-coding RNA expression profiles in gastric cancer, " World Journal of Gastroenterology, vol. 19, no. 23, pp. 3658-3664, 2013.
62. L. Cui, X. Zhang, G. Ye et al., "Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer, " Cancer, vol. 119, no. 9, pp. 1618-1626, 2013.
63. J. R. Prensner and A. M. Chinnaiyan, "The emergence of lncRNAs in cancer biology, " Cancer Discovery, vol. 1, no. 5, pp. 391-407, 2011.